Latest Commercialisation News

Brazilian Critical Minerals has reported sustained high-grade rare earth element recovery from its in-situ recovery trials at the Ema Project, with pregnant leach solution grades exceeding 5,700 ppm TREO and strong magnet rare earth oxide content.

ChemX Materials Limited has entered voluntary administration following a turbulent quarter marked by convertible note amendments, a trading suspension, and ongoing funding challenges.

1414 Degrees has addressed a sharp rise in its share price and trading volume, attributing the market interest to recent climate policy recommendations and ongoing commercial efforts.

NoviqTech has launched beta versions of its pioneering quantum AI products, QI Provenance and QI AI, marking a significant step toward commercialising hybrid quantum-classical computing solutions. The company also announced plans for a powerful CUDA-Q enhanced platform promising up to tenfold acceleration in complex computing tasks.

Proteomics International Laboratories has achieved ISO 15189 certification for its Australian lab, marking a pivotal step in commercialising its precision diagnostic tests like PromarkerD and PromarkerEso.

Memphasys has upgraded its contract with ITL to A$390,000 and expanded its territory to include Turkey, marking its first contracted revenues in the EU ahead of expected CE Mark approval.

Iondrive Limited has inked a binding Term Sheet with Livium Limited to commercialise its innovative Deep Eutectic Solvent (DES) technology for recycling critical materials from batteries, solar panels, and e-waste in Australia, with a pilot plant set to begin commissioning by the end of 2025.

Livium Ltd has entered a binding term sheet with Iondrive Limited to collaborate on recycling end-of-life solar panels, lithium-ion battery black mass, and rare earth magnets using Iondrive’s innovative Deep Eutectic Solvent (DES) technology. This partnership aims to position both companies at the forefront of Australia’s emerging clean energy waste recycling market.

EMVision Medical Devices has raised $12 million through a placement backed by institutional investors, including strategic partner Keysight Technologies, and launched a Share Purchase Plan to raise up to $2 million from existing shareholders. The capital will support key clinical and regulatory milestones for its neurodiagnostic devices over the next two years.

EBR Systems has achieved a significant commercial milestone with its tenth US implant of the WiSE wireless cardiac pacing system, setting the stage for broader market adoption supported by new reimbursement schemes.

OD6 Metals has launched a metallurgical diamond core drilling program at its Splinter Rock Rare Earth Project, aiming to refine heap leach processing and produce high-quality rare earth samples for offtake talks.

Global Laser Enrichment, Silex’s exclusive licensee, has completed large-scale uranium enrichment testing, advancing the SILEX technology closer to commercial deployment in the US nuclear fuel market.